CNS Drugs

Aims & Scope

CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology.

The Journal includes: - Overviews of contentious or emerging issues. - Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses. - Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry. - Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content.

In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	7.4
2024	7.40

SJR (SCImago Journal Rank)

Year	Value
2024	1.884

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	132

Journal Rank

Year	Value
2024	1607

Journal Citation Indicator

Year	Value
2024	1647

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Internet Addiction

  Citation: 601

  Authors: Martha, Donald W

• Pharmacological and Therapeutic Properties of Valproate

  Citation: 554

  Authors: Emilio

• Basic Pharmacology of Valproate

  Citation: 534

  Authors: Wolfgang

• Second-Generation (Atypical) Antipsychotics and Metabolic Effects

  Citation: 486

  Authors: John W.

• Cognitive Effects of Long-Term Benzodiazepine Use

  Citation: 429

  Authors: Melinda J, Kenneth M, Martin, Simon F

• Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

  Citation: 392

  Authors: Jessica, Manfred, William H., Yvonne F., Colin D., Christian, Suzanne, Fernanda G., Christian

• Neuropsychiatric Adverse Effects of Interferon-??

  Citation: 389

  Authors: Charles L, Marina, Lucile, Andrew H

• A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

  Citation: 376

  Authors: Lesley, Barry, Graham, Bola, Gilmour

• Getting into the Brain

  Citation: 374

  Authors: Mayur M, Bhoomika R, Shraddha V, Jay S, Avani F

• Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

  Citation: 364

  Authors: Jiri, Vera, Milan, Tomas, Colleen, Pavel, Cyril

---